4.8 • 3.1K Ratings
🗓️ 25 March 2025
⏱️ 70 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | Hi, I'm Christina Applegate. |
0:02.6 | And I'm Jamie Lynn Sigler. |
0:04.1 | And this is messy. |
0:10.5 | The following message is brought to you by Novartis. |
0:17.5 | Since partnering with Novartis, I have been thinking a lot about when I was diagnosed with relapsing MS. |
0:22.6 | I kept it a secret at first, and that robbed me of the support I really needed. |
0:27.6 | I finally found the courage to open up about it and quickly learn the importance of speaking up. |
0:32.6 | That means making your voice the loudest in the room. |
0:35.6 | You have to find an MS specialist who's the |
0:38.2 | right fit, who makes you feel seen and heard. It's kind of like dating. That's why I partnered with |
0:44.1 | Novartis to create a three-step guide, to inspire others to own their RMS journeys, recognize their |
0:50.6 | needs, and find a treatment that works for them. Learn more about my story at |
0:55.2 | reframingMS.com. |
1:01.1 | Hello, everybody. Welcome to Messy. I'm Jamie. I'm Christina. And today is a special day. |
1:12.8 | Big. |
1:13.7 | Big day. |
1:15.0 | We've talked about this man and all that he has given us a lot. |
1:19.8 | Probably just as much, if not more, about MS. |
1:23.8 | We talk about Bravo. |
1:25.8 | Our guest today is an Emmy Award-winning host, producer, an author. |
1:32.1 | He's single-handedly responsible for filling up all of Christina's time when she's not being a mom or on this podcast. |
1:39.9 | He's everyone's favorite, Zaddy. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Wishbone Production, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Wishbone Production and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.